本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cogent Biosciences, Inc.

36.10
-0.7700-2.09%
盤後36.100.00000.00%16:34 EDT
成交量:154.29萬
成交額:5,604.29萬
市值:58.59億
市盈率:-16.71
高:37.01
開:36.10
低:35.78
收:36.87
52周最高:43.73
52周最低:3.72
股本:1.62億
流通股本:1.43億
量比:0.57
換手率:1.08%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
淨資產收益率:-73.70%
總資產收益率:-32.93%
市淨率:10.71
市盈率(LYR):-14.15

資料載入中...

2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/08

重要事件披露

Form 8-K - Current report
2023/06/08

重要事件披露

Form 8-K - Current report
2023/06/06

重要事件披露

Form 8-K - Current report
2023/06/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/14

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/14

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/14

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals